ACCORD
2008
Action to Control Cardiovascular Risk in Diabetes
In 10,251 patients with long-standing T2DM and CV disease or risk factors, intensive glucose control targeting HbA1c <6.0 % increased all-cause mortality compared with standard control (7.0–7.9 %).
Result
Efficacy: Non-fatal MI, non-fatal stroke or CV deathHR 0.90 (95% CI 0.78-1.04) · P = 0.16
Safety: All-cause mortalityHR 1.22 (95% CI 1.01-1.46) · P = 0.04
Below 1 favours intensive glucose control targeting HbA1c <6.0 %, above 1 favours standard control (7.0–7.9 %).
- Subtopic
- Intensive vs standard glycaemia
- Design
- RCT, stopped early at 3.5 yr
- Relevance
- Practice-defining: a trial the field needs to know.
- Source
- ACCORD Study Group. N Engl J Med. 2008;358(24):2545-2559.doi 10.1056/NEJMoa0802743
Discussion & critique
Established the harm of over-aggressive glucose-lowering in long-standing T2DM and underpins individualised HbA1c targets.